Last reviewed · How we verify

NCT05696197

Learning Potential of Patients With Parkinson's Disease After Two Weeks of Targeted Touchscreen Training

Completed NA Last updated 23 January 2025
What this trial tests

NA trial testing Targeted touchscreen training in Parkinson Disease in 36 participants. Completed in 31 January 2023.

Timeline
10 January 2022
Primary endpoint
19 January 2023
31 January 2023

Quick facts

Lead sponsorKU Leuven
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment36
Start date10 January 2022
Primary completion19 January 2023
Estimated completion31 January 2023
Sites1 location across Belgium

Drugs / interventions tested

Conditions studied

Sponsor

KU Leuven — full company profile →

Who can join

Eligibility, any sex, with Parkinson Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Parkinson's disease (PD) is characterized by severe motor and non-motor symptoms, including upper limb dysfunction. Due to the degradation of dopaminergic neurons in the striatum, PD patients experience difficulties with motor learning and more specifically with the consolidation of motor memory. Recent work showed that intensive writing training improved writing skills in PD. Although consolidation effects were present, difficulties with retention were also still apparent. Besides impacting writing, manual dexterity deficits in PD can also affect the use of touchscreens. Researchers from our lab demonstrated that impairments were most pronounced in multi-direction sliding motions, indicating the need for training of these motor skills. Our lab demonstrated the classic difficulties with retention in PD after one session of training of a swipe and slide pattern on a tablet (SSP-task) as single task (ST), although immediate gains were demonstrated. Therefore, in this study the investigators will examine whether a two-week home-based training program of a tablet-based SSP-training program will lead to immediate and consolidated improvements that are retained in time. This program will combine ST and dual task (DT) training to provide variation during the training period, but also to increase the cognitive challenge during learning, thereby stimulation consolidation of learning. The primary aim of this study consists of investigating the learning effects after two weeks of targeted touchscreen training. Secondary, the investigators will examine whether these effects will also be retained after four weeks without practice and whether targeted training results in consolidated improvements, in terms of automaticity and transfer towards an untrained task. Given the objective recording of compliance to the training protocol, the investigators will explore the association between compliance rates and learning effects.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Using Digital Outcomes to Measure Meaningful Aspects of Health in Clinical Trials for Parkinson's Disease: A Scoping Review.
    van Es MJ, Timmermans NA, Meinders MJ, Nolen WA, et al · · 2026 · PMID 42077420 · DOI 10.1159/000550956

Verify or expand the search:

Other recruiting trials for Parkinson Disease

Currently open trials in the same condition.

Other KU Leuven trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05696197.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing